Genetic variation in IL28B (IFNL3) and response to interferon-alpha treatment in myeloproliferative neoplasms
The results of this retrospective study of 100 patients with myeloproliferative neoplasms treated with interferon-alpha show that the IL28B genotype may affect treatment outcome.
European Journal of Haematology
In The News
American Journal of Managed Care
In The Literature
American Journal of Hematology European Journal of Haematology